SLC9A1 and cancer: However, paclitaxel itself can inhibit NHE1, and this may be causal in the induction of apoptosis induced by this and other cancer therapeutics, or the inhibition may be due to apoptotic cleavage of NHE1 as previously mentioned [75, 79–81].